India supplies a substantial share of global generic pharmaceuticals - including iron chelators like Deferasirox. Here is why India has become a trusted source for procurement teams worldwide.
1. Regulatory Maturity #
- Central Drugs Standard Control Organization (CDSCO) with international alignment
- State FDAs conducting WHO-GMP inspections
- Growing PIC/S-alignment; CDSCO PIC/S application in progress
- Multiple manufacturers hold US FDA, EMA, TGA, PMDA and WHO-PQ approvals
2. Manufacturing Scale & Quality #
- Large-scale oral-solids production with modern equipment
- Robust API ecosystem allowing vertical integration
- Expanding investment in continuous manufacturing and digital quality systems
- Strong talent pool in pharmaceutical sciences and engineering
3. Cost Advantage #
- Favourable input cost base (labour, energy, infrastructure)
- Scale economies from serving domestic + export markets
- Direct API-to-finished-dose integration reduces intermediate mark-ups
4. Registration Documentation Readiness #
Indian manufacturers routinely maintain CTD-format dossiers, WHO-format CoPPs and bioequivalence packages - meeting regulator expectations in LATAM, Africa, Asia and CIS.
5. Public-Health Role #
India's generic pharmaceutical industry has historically played a decisive role in HIV, TB and malaria access programmes. The same infrastructure supports iron-chelation access for thalassemia and SCD populations worldwide.
6. Taj Pharma as a Representative Manufacturer #
- WHO-GMP certified Sarigam, Gujarat facility
- Full CTD dossier for DEFRATAJ Deferasirox (5 strengths)
- ISO 9001:2015 certified
- Multi-continent supply track record